Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Ross

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
AIDS (London, England)|December 22, 2009
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who shouldIngrid V Bassett, Susan Regan, Senica Chetty, et al.
AIDS (London, England)|April 17, 2010
Outcomes after virologic failure of first-line ART in South AfricaRichard A Murphy, Henry Sunpath, Zhigang Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patientsNaoko Takebe, Xiangfei Cheng, Suhlan Wu, et al.
Plos One|February 6, 2013
Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South AfricaPaul K Drain, Elena Losina, Gary Parker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South AfricaVincent C Marconi, Henry Sunpath, Zhigang Lu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2017
Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South AfricaIngrid V Bassett, Sharon M Coleman, Janet Giddy, et al.
Plos One|March 9, 2010
The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South AfricaElena Losina, Ingrid V Bassett, Janet Giddy, et al.
BMC Infectious Diseases|August 27, 2013
A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trialIngrid V Bassett, Janet Giddy, Christine E Chaisson, et al.
Thyroid : Official Journal of the American Thyroid Association|July 9, 2009
The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug AdministrationRebecca S Bahn, Henry S Burch, David S Cooper, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 16, 2016
Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South AfricaIngrid V Bassett, Sharon M Coleman, Janet Giddy, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|December 22, 2009
Who starts antiretroviral therapy in Durban, South Africa?... not everyone who shouldIngrid V Bassett, Susan Regan, Senica Chetty, et al.
AIDS (London, England)|April 17, 2010
Outcomes after virologic failure of first-line ART in South AfricaRichard A Murphy, Henry Sunpath, Zhigang Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2004
Phase I clinical trial of the inosine monophosphate dehydrogenase inhibitor mycophenolate mofetil (cellcept) in advanced multiple myeloma patientsNaoko Takebe, Xiangfei Cheng, Suhlan Wu, et al.
Plos One|February 6, 2013
Risk factors for late-stage HIV disease presentation at initial HIV diagnosis in Durban, South AfricaPaul K Drain, Elena Losina, Gary Parker, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 19, 2008
Prevalence of HIV-1 drug resistance after failure of a first highly active antiretroviral therapy regimen in KwaZulu Natal, South AfricaVincent C Marconi, Henry Sunpath, Zhigang Lu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 7, 2017
Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South AfricaIngrid V Bassett, Sharon M Coleman, Janet Giddy, et al.
Plos One|March 9, 2010
The "ART" of linkage: pre-treatment loss to care after HIV diagnosis at two PEPFAR sites in Durban, South AfricaElena Losina, Ingrid V Bassett, Janet Giddy, et al.
BMC Infectious Diseases|August 27, 2013
A randomized trial to optimize HIV/TB care in South Africa: design of the Sizanani trialIngrid V Bassett, Janet Giddy, Christine E Chaisson, et al.
Thyroid : Official Journal of the American Thyroid Association|July 9, 2009
The Role of Propylthiouracil in the Management of Graves' Disease in Adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug AdministrationRebecca S Bahn, Henry S Burch, David S Cooper, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 16, 2016
Sizanani: A Randomized Trial of Health System Navigators to Improve Linkage to HIV and TB Care in South AfricaIngrid V Bassett, Sharon M Coleman, Janet Giddy, et al.
Pageof 9